Remove DEA Remove Document Remove Safety
article thumbnail

Intoxicating Hemp Swindle

Project CBD

Devitt expresses serious safety concerns. In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary.

Hemp 233
article thumbnail

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.

DEA 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis Litigation: Second Circuit Could Force DEA to Re- or Deschedule Marijuana

Canna Law Blog

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Schedule I is reserved for drugs with a high potential for abuse, no currently accepted medical uses, and a lack of accepted safety for medical use.

DEA 108
article thumbnail

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Cannabis Law Report

Drug Enforcement Agency (“DEA”). When pressed by CEC’s lawyers, CBP was able to sort through these 966 and identify information in the seizure documents that identified the seized materials as brown liquid or brown paste. Customs Border Patrol (“CBP”) and U.S. Department of the Navy , 562 U.S. 562 [2011]).

DEA 97
article thumbnail

Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics

Cannabis Law Report

A 28-page DEA report — authored in August of 2021, and based on Department of Health and Human Services reviews of these psychedelics from 2012 — states, “These five tryptamines have no known medical use in the United States and are not marketed internationally as approved drug products. Read full report at.

DEA 52
article thumbnail

New Hemp Testing Guidelines Make Meeting 0.3% THC Limit Difficult

Medicinal Genomics

However, the document also states “the cut shall be made just underneath a flowering material”. This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. New Sampling Guidelines. This guidance is in line with the common international standards.

THC 81
article thumbnail

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45